Related Experiment Video
Updated: Jun 6, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Myocardial Performance Index to assess cardiac function in autoimmune connective tissue disease: a systematic review
Rudy Hidayat1,2, Sally Aman Nasution3, Faisal Parlindungan4,2
1Rheumatology Division, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Insights
This study found elevated Myocardial Performance Index (MPI) in patients with autoimmune connective tissue diseases (ACTD). MPI may aid in the early detection of cardiac dysfunction in these patients.
Area of Science:
- Cardiology
- Rheumatology
- Medical Diagnostics
Background:
- Autoimmune connective tissue diseases (ACTD) can affect cardiac function.
- Early detection of cardiac abnormalities in ACTD patients is crucial for management.
- Myocardial Performance Index (MPI) is a potential echocardiographic marker for cardiac function.
Purpose of the Study:
- To evaluate cardiac function using MPI in ACTD patients without overt cardiovascular abnormalities.
- To systematically review and meta-analyze studies assessing MPI in various ACTD.
- To determine if MPI is elevated in ACTD patients compared to healthy controls.
Main Methods:
- Systematic literature search of Medline, Google Scholar, Scopus, and Cochrane Library (1995-2023).
- Included ACTD: rheumatoid arthritis, systemic sclerosis, systemic lupus erythematosus, Sjögren syndrome.
- Meta-analysis of MPI using Review Manager V.5.4 after quality assessment with Newcastle-Ottawa Scale.
Main Results:
- Included 22 studies (19 for quantitative synthesis) covering RA, SSc, SLE, SjD, and mixed connective tissue disorder.
- Both conventional and tissue Doppler imaging (TDI) MPI values were significantly elevated in ACTD patients versus controls.
- p < 0.00001 for both conventional (MD=0.11) and TDI MPI (MD=0.06).
Conclusions:
- Patients with ACTD exhibit elevated MPI values compared to healthy individuals.
- MPI shows potential for early detection and management of cardiac dysfunction in ACTD.
- Further research is needed to confirm these findings and their clinical implications.
Objectives:
This study aimed to evaluate cardiac function using Myocardial Performance Index (MPI) in autoimmune connective tissue disease (ACTD) patients without cardiovascular abnormalities.
Methods:
A systematic search of databases including Medline, Google Scholar, ProQuest, Scopus and Cochrane Library was conducted to identify relevant studies on ACTD and MPI from 1995 to 2023. ACTD included in the search were rheumatoid arthritis (RA), systemic sclerosis (SSc), systemic lupus erythematosus (SLE), Sjögren syndrome (SjD), polymyositis and dermatomyositis. Quality assessment was performed using the Newcastle-Ottawa Scale, followed by meta-analysis computation of mean differences (MDs) of MPI using Review Manager V.5.4.
Results:
A total of 22 studies for qualitative and 19 for quantitative synthesis were included. We found six studies on RA, eight studies on SSc, five studies on SLE, two studies on SjD and one on mixed connective tissue disorder. Conventional echocardiography and tissue Doppler imaging (TDI) were used to assess the MPI. Both conventional MPI and tissue Doppler MPI values were elevated compared with healthy control (MD=0.11, 95% CI 0.08 to 0.14, p value<0.00001 and MD=0.06, 95% CI 0.03 to 0.10, p value=0.00001, respectively).
Conclusions:
We found elevated MPI values in patients with ACTD compared with healthy controls. MPI assessment has the potential for early detection and management of cardiac dysfunction in patients with ACTD, but further studies are required to corroborate these findings.
Prospero Registration Number:
CRD42023490643.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis II: Clinical features and Diagnostic Tests

